Canine hip dysplasia: Evidence-based treatment

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 24, Issue 8, 2002, Pages 590-599

  Kapatkin, Amy S ^a   Mayhew, Philipp D ^a   Smith, Gail K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036669888     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Clinical hip dysplasia in growing dogs: The long-term results of conservative management
2. Nonsurgical management of severe hip dysplasia: Long-term results
3. Evaluation of biocompatible osteoconductive polymer as an orthopedic implant in dogs
4. Evaluation of shelf arthroplasty as a treatment for hip dysplasia in dogs
5. Canine hip dysplasia: Differences in pectineal muscles of healthy and dysplastic German shepherd dogs when two months old
6. Alternative surgical treatments for canine hip dysplasia
7. Association between pelvic muscle mass and canine hip dysplasia
8. Pectineus tendonectomy: A procedure for treating clinical canine hip dysplasia
9. Canine hip dysplasia: Past and present
10. Triple pelvic osteotomy: Effect on limb function and progression of degenerative joint disease
11. Preoperative variables affecting long-term outcome of triple pelvic osteotomy for treatment of naturally developing hip dysplasia in dogs
12. Force-plate analysis of dogs with bilateral hip dysplasia treated with a unilateral triple pelvic osteotomy: A long-term review of cases
13. Radiographic evaluation and comparison of plate fixation after triple pelvic osteotomy in 32 dogs with hip dysplasia
14. Triple osteotomy of the pelvis as a treatment for canine hip dysplasia
15. Triple osteotomy of the pelvis and trochanteric osteotomy as a treatment for hip dysplasia in the immature dog: The surgical technique and results of 77 consecutive operations
16. Pelvic osteotomy technique for axial rotation of the acetabular segment in dogs
17. Pelvic osteotomy (abstract)
18. Pelvic osteotomy in the dog as treatment for hip dysplasia
19. Pelvic osteotomy for axial rotation of the acetabular segment in dogs with hip dysplasia
20. Long-term results of conservative treatment, excision arthroplasty, and triple pelvic osteotomy for the treatment of hip dysplasia in the immature dog. Part I: Radiographic and physical results
21. Long-term results of conservative treatment, excision arthroplasty, and triple pelvic osteotomy for the treatment of hip dysplasia in the immature dog. Part 2: Analysis of the ground reaction forces
22. Influence of body condition on canine osteoarthritis
23. Evaluation of risk factors for degenerative joint disease associated with canine hip dysplasia in German Shepherd dogs, golden retrievers, Labrador retrievers, and rottweilers
24. Treatment methods for pain in the osteoarthritic patient
25. Mechanisms of action of antiinflammatory medications used for the treatment of osteoarthritis
26. Nonsteroidal antiinflammatory analgesics for acute pain management in dogs and cats
27. Hepatocellular toxicosis associated with administration of carprofen in 21 dogs
28. Pathophysiology, diagnosis, and treatment of canine hip dysplasia
29. How I treat canine hip dysplasia
30. A review of aseptic loosening in total hip arthroplasty
31. Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs
32. The therapeutic efficacy of carprofen (Rimadyl-V™) in 209 clinical cases of canine degenerative joint disease
33. Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal antiinflammatory drug, in the treatment of osteoarthritis in dogs
34. Analgesia and nonaspirin, nonsteroidal antiinflammatory drugs for osteoarthritis of the hip
35. Nutraceuticals in veterinary medicine. Parr I. Definitions and regulations
36. Slow-acting, disease-modifying osteoarthritis agents
37. Oral chondroprotective agents. Part I. Common compounds
38. Nutraceuticals in veterinary medicine. Part II. Safety and efficacy
39. Oral chondroprotective agents. Part II. Evaluation of products
40. Long-term effects of glucosamine sulphate on osteoarthritis progression: A randomized, placebo-controlled clinical trial
41. Osteoarthritis: New insights. Part 2: Treatment approaches
42. The role of exercise and physical modalities in the treatment of osteoarthritis
43. Exercise in the treatment of osteoarthritis
44. Supervised fitness walking in patients with osteoarthritis of the knee
45. Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: A randomised controlled trial
46. Physical therapy for critically ill veterinary patients. Part II. The musculoskeletal system
47. Effect of weight reduction on clinical signs of lameness in dogs with hip osteoarthritis
48. Weight loss to optimal body condition increases ground reactive force in dogs with osteoarthritis
49. Effects of limited food consumption on the incidence of hip dysplasia in growing dogs
50. Five-year longitudinal study on limited food consumption and development of osteoarthritis in coxofemoral joints in dogs
51. Estimation of body fat by body condition score
52. Obesity management in dogs
53. Gait analysis of dogs with hip dysplasia treated with gold bead implantation acupuncture